BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16910673)

  • 1. A fluoro analogue of the menadione derivative 6-[2'-(3'-methyl)-1',4'-naphthoquinolyl]hexanoic acid is a suicide substrate of glutathione reductase. Crystal structure of the alkylated human enzyme.
    Bauer H; Fritz-Wolf K; Winzer A; Kühner S; Little S; Yardley V; Vezin H; Palfey B; Schirmer RH; Davioud-Charvet E
    J Am Chem Soc; 2006 Aug; 128(33):10784-94. PubMed ID: 16910673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-substituted tetrazoles as bioisosteres of carboxylic acids. Bioisosterism and mechanistic studies on glutathione reductase inhibitors as antimalarials.
    Biot C; Bauer H; Schirmer RH; Davioud-Charvet E
    J Med Chem; 2004 Nov; 47(24):5972-83. PubMed ID: 15537352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aza-analogues of 1,4-naphthoquinones are potent substrates and inhibitors of plasmodial thioredoxin and glutathione reductases and of human erythrocyte glutathione reductase.
    Morin C; Besset T; Moutet JC; Fayolle M; Brückner M; Limosin D; Becker K; Davioud-Charvet E
    Org Biomol Chem; 2008 Aug; 6(15):2731-42. PubMed ID: 18633531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
    Davioud-Charvet E; McLeish MJ; Veine DM; Giegel D; Arscott LD; Andricopulo AD; Becker K; Müller S; Schirmer RH; Williams CH; Kenyon GL
    Biochemistry; 2003 Nov; 42(45):13319-30. PubMed ID: 14609342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones--a new strategy to combat malarial parasites.
    Müller T; Johann L; Jannack B; Brückner M; Lanfranchi DA; Bauer H; Sanchez C; Yardley V; Deregnaucourt C; Schrével J; Lanzer M; Schirmer RH; Davioud-Charvet E
    J Am Chem Soc; 2011 Aug; 133(30):11557-71. PubMed ID: 21682307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the trifluoromenadione core as a template to design antimalarial redox-active agents interacting with glutathione reductase.
    Lanfranchi DA; Belorgey D; Müller T; Vezin H; Lanzer M; Davioud-Charvet E
    Org Biomol Chem; 2012 Jun; 10(24):4795-806. PubMed ID: 22618151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of active site tyrosine residues in catalysis by human glutathione reductase.
    Krauth-Siegel RL; Arscott LD; Schönleben-Janas A; Schirmer RH; Williams CH
    Biochemistry; 1998 Oct; 37(40):13968-77. PubMed ID: 9760231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crystal structure of Plasmodium falciparum glutamate dehydrogenase, a putative target for novel antimalarial drugs.
    Werner C; Stubbs MT; Krauth-Siegel RL; Klebe G
    J Mol Biol; 2005 Jun; 349(3):597-607. PubMed ID: 15878595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferredoxin-NADP+ reductase from Plasmodium falciparum undergoes NADP+-dependent dimerization and inactivation: functional and crystallographic analysis.
    Milani M; Balconi E; Aliverti A; Mastrangelo E; Seeber F; Bolognesi M; Zanetti G
    J Mol Biol; 2007 Mar; 367(2):501-13. PubMed ID: 17258767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
    Friebolin W; Jannack B; Wenzel N; Furrer J; Oeser T; Sanchez CP; Lanzer M; Yardley V; Becker K; Davioud-Charvet E
    J Med Chem; 2008 Mar; 51(5):1260-77. PubMed ID: 18260613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional diversity of ferredoxin-NADP(+) reductases.
    Aliverti A; Pandini V; Pennati A; de Rosa M; Zanetti G
    Arch Biochem Biophys; 2008 Jun; 474(2):283-91. PubMed ID: 18307973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: crystallographic, kinetic, and spectroscopic studies.
    Gallwitz H; Bonse S; Martinez-Cruz A; Schlichting I; Schumacher K; Krauth-Siegel RL
    J Med Chem; 1999 Feb; 42(3):364-72. PubMed ID: 9986706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Acetylamino-3-[4-(2-acetylamino-2-carboxyethylsulfanylcarbonylamino)- phenylcarbamoylsulfanyl]propionic acid and its derivatives as a novel class of glutathione reductase inhibitors.
    Seefeldt T; Dwivedi C; Peitz G; Herman J; Carlson L; Zhang Z; Guan X
    J Med Chem; 2005 Aug; 48(16):5224-31. PubMed ID: 16078841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplasmodial activity of quinones: roles of aziridinyl substituents and the inhibition of Plasmodium falciparum glutathione reductase.
    Grellier P; Maroziene A; Nivinskas H; Sarlauskas J; Aliverti A; Cenas N
    Arch Biochem Biophys; 2010 Feb; 494(1):32-9. PubMed ID: 19919822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ferredoxin-NADP+ reductase/ferredoxin electron transfer system of Plasmodium falciparum.
    Balconi E; Pennati A; Crobu D; Pandini V; Cerutti R; Zanetti G; Aliverti A
    FEBS J; 2009 Jul; 276(14):3825-36. PubMed ID: 19523113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human glutathione reductase by 10-arylisoalloxazines: crystalline, kinetic, and electrochemical studies.
    Schönleben-Janas A; Kirsch P; Mittl PR; Schirmer RH; Krauth-Siegel RL
    J Med Chem; 1996 Mar; 39(7):1549-54. PubMed ID: 8691487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the intersubunit cavity of Plasmodium falciparum glutathione reductase by a novel natural inhibitor: computational and experimental evidence.
    Tyagi C; Bathke J; Goyal S; Fischer M; Dahse HM; Chacko S; Becker K; Grover A
    Int J Biochem Cell Biol; 2015 Apr; 61():72-80. PubMed ID: 25660424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the glyoxalases of the malarial parasite Plasmodium falciparum and comparison with their human counterparts.
    Akoachere M; Iozef R; Rahlfs S; Deponte M; Mannervik B; Creighton DJ; Schirmer H; Becker K
    Biol Chem; 2005 Jan; 386(1):41-52. PubMed ID: 15843146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding nicotinamide dinucleotide cofactor and substrate specificity in class I flavoprotein disulfide oxidoreductases: crystallographic analysis of a glutathione amide reductase.
    Van Petegem F; De Vos D; Savvides S; Vergauwen B; Van Beeumen J
    J Mol Biol; 2007 Dec; 374(4):883-9. PubMed ID: 17977556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium falciparum glyoxalase II: Theorell-Chance product inhibition patterns, rate-limiting substrate binding via Arg(257)/Lys(260), and unmasking of acid-base catalysis.
    Urscher M; Deponte M
    Biol Chem; 2009 Nov; 390(11):1171-83. PubMed ID: 19663684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.